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1. Introduction   
The non steroid anti-inflammatory drugs (NSAID) are among the most prescribed because 
of their analgesic and anti-inflammatory properties [1].The derivatives of the acid 
aminosalicylic (4ASA and 5-ASA) are used since many years in the treatment of the 
intestinal chronic inflammatory diseases: Crohn disease and colitis. Aminosalicylic acids 
exert a direct anti- inflammatory action on the intestinal mucous membranes. They do not 
have any link with the drugs of cortisone family, or with traditional NSAID used for pain 
and rheumatism. They are also different from the acetylsalicylic acid (Aspirine®).  
4ASA also known under the name of paramino benzoïc acid (PABA) or paramino salicylic acid 
(PASA) (figure 1) is employed for the treatment of the ulcerative colitis and Crohn disease. 
These diseases are characterized by an ignition of the colorectal mucous membrane [2]. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Molecular structure of 4ASA 
NH2
O OH
OH
www.intechopen.com
 
Inflammatory Bowel Disease – Advances in Pathogenesis and Management 166 
In the literature, several analytical methods primarily based on separation were described. 
Therefore, quantitative methods to assay, for instance a drug substance or its impurities, have 
needed to be fully validated after development. Depending on the type of analytical method 
and its intended use, a check for linearity, precision, accuracy, specificity, range, limits of 
detection and quantification, and/or robustness, is required [3-7], gas chromatography 
coupled with the mass spectrometry were the most usually used methods for analytes 
separation [8]. A capillary method of electrophoresis was developed for 4ASA 
determination and its metabolites: acid N-acetyl-p-aminosalicylic (N-acetyl-PASA) in urine. 
Good separation of analytes was carried out with a 12 min retention time for15min [9]. 
4ASA is also quantified by HPLC in the biological fluids [10, 11]. In this present article, we 
describe the development of a new RP-HPLC method for the determination of 4ASA  at 
the same time in both aqueous medium and plasma.  
2. Material and methods 
4ASA was supplied by Merck (Hohenbrunn, Germany). Formic acid (99-100%) was 
provided by Prolabo. Potassium dihydrogene phosphate (KH2PO4), acetonitrile (MeCN) 
and  potassium hydroxide (KOH) were provided by SDS (Peypin, France). Alpha 
cyclodextrine was purchased from Waker and Gelucire® from Gattefossé (France). Sodium 
citrate was obtained from Sigma chemical Co (USA). Water purified on Milli-Q system 
(Millipore, USA) was used. All other chemicals were of analytical grade. 
2.1 Instrumentation   
The liquid chromatographic system used in the present study, consisted of a pump (880-
Jasco, Japan), an automatic injector (autosampler HPLC -360Kontron, Brehme, Germany) 
and a detector (Jasco 875-UV). All the parameters of HPLC were controlled by the Azur 
software: version 3.0 coupled to an acquisition box (Azur PAD). 
2.2 Chromatographic conditions  
The mobile phase was prepared by mixing water, formic acid and acetonitrile in varied 
proportions. The optimum mobile phase used in the validation studies consisted of water-
formic acid-acetonitrile 67:3:30, (v/v/v). Before analysis the mobile phase was filtered 
through a 0.45µm membrane and degassed by ultra sonication (Transsonic 950, Prolabo).  
Solvent delivery was employed at a flow rate of 1.0 ml min -1. A Kromasil column:  C-18µm, 
250mm ×4.6mm (Chromato, France HAS) was used and maintained at room temperature.  
Detection of the analytes was carried out at 300nm.The appropriate wavelength for the 
detection of the drug was determined by wavelength scanning over the range of 200-400nm. 
Injection volume of the analytes was set to a constant volume of 50µl. 
2.3 Validation of the method  
The described method has been validated in terms of specificity, precision, linearity, 
accuracy, limit of detection (LOD) and limit of quantification (LOQ). 
2.3.1 Precision 
Precision was expressed with respect to the intra and inter-day variations in the expected 
drug concentrations. 
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2.3.2 Linearity  
Data were obtained using a stock solution of 4ASAS at 0.5 mg.ml-1 as concentration. This 
solution was then diluted using highly purified water to obtain the standard solutions from 
1 to 125µg/ml concentrations. Five injections were made for each concentration. The 
linearity of the calibration curves was determined on three different days for intra or inter-
day variation.   
2.3.3 Accuracy  
Accuracy of the proposed method was established by recovery experiments using standard 
addition method. This study was employed by addition of a standard reference (pure 
marketed product whose purity was tested beforehand by Differential Scanning 
Calorimetry (DSC) and Fourier transformed Infrared Spectrometry (FT-IR). 
2.3.4 Robustness 
An experimental design was used to evaluate the influence of selected factors. Two-level 
factorial design was used (Table 1). 
 
 
Table 1. Influence of selected factors: MeCN (%), Wavelength (nm), Flow rate (ml/min) and 
pH on the robustness of the method:  
For this method only factors were examinated: acetonitrile ratio, wavelength, flow rate  
and pH.   
2.3.5 Limit of detection and limit of quantification 
Several approaches were used to determine the detection and quantitation limits. These 
include visual evaluation, signal-to-noise ratio, the use of standard deviation of the response 
and the slope of the calibration curve.  
In the present study, the LOD was related to signal / noise of the system and was defined as 
a peak whose report/ration signal background noise was at least equal to 3/1. The LOQ was 
defined as a peak whose report/ ratio signal background noise was at least equal to 10/1. 
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The determination of these values was made starting from the line of the range standard. 
These two values were calculated from the Response Factor (Rf) according to formulas (1) 
and (2): the initial concentration corresponds to the intersection of the right-hand side to the 
y-axis [12].  
                Fr = ୗ୲ୟ୬ୢୟ୰ୢ	ୟ୰ୣୟ୍୬୧୲୧ୟ୪	େ୭୬ୡୣ୬୲୰ୟ୲୧୭୬     (1) 
  
Sample	concentration = ௌ௔௠௣௟௘	௔௥௘௔ி௥        (2) 
2.3.6 Stability  
Experiments were carried out under the same conditions as the samples analysis. 
2.3.7 Recovery test  
Recovery test was carried out by weighing three batches of pellets (containing 50% of 4ASA) 
compared with a powder sample of pure active ingredient. Amounts representing 120,100 
and 80% of 4ASA were used as equivalent concentrations. Each batch is crushed using a 
mortar then filtered before being solubilized in 250ml water with respect of sink conditions. 
The release properties of the active ingredient from the extruded formulations matrix were 
studied by using a process of the delayed release. The medium of dissolution was 
maintained at 37°C with 100 rpm stirring. After 6 hours, three samples of 1 ml were taken in 
each sample of buffer solution of phosphate potassium (0.2 M) whose pH was adjusted to 
7.5 using a potassium hydroxide buffer (KOH 1M).  
3. Application to biological samples 
The proposed method was applied to the determination of 4ASA in plasma samples from 
the bioequivalence study. In vivo studies of 4ASA blood concentration were carried out by 
using established methods of the literature [10]. Male Sprague-Dawley rats weighing 200–
250g (n = 4) were purchased from Charles Rivers Enterprise (France) and kept in laboratory 
conditions before experiments. 
3.1 Linearity and precision 
Linearity was assessed by analyzing seven standards with concentrations over the range of 
10-100µg/ml in plasma (n=5). Precision and accuracy were tested comparing to the values 
obtained previously in aqueous solution. Aliquot of 1000µl plasma were mixed with 500µl of 
standard solution of 4ASA. The mixture was vortexed for 2 min and transferred into the vial 
for HPLC analysis (n=8). 
3.2 Recovery test in plasma  
For recovery test, three samples of 1000µl plasma were mixed with 250µl of standard 
solution (25, 50 and 100µg/ml) of 4ASA. The mixture was vortexed for 2 min and 
transferred into the vial for HPLC analysis (n=5).  
3.3 Stability test in plasma 
Drug stability during sample collection and processing is an important factor for clinical 
bioanalysis. Three samples of 1000µl plasma were mixed with 500µl of standard solution of 
4ASA and analyzed at 0 and 24hours at room temperature and at 4°C (n=5). 
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3.4 Blood-plasma partition ratio 
Blood-plasma partition ratio would predict plasma concentration-time courses following 
4ASA oral doses to rats.  
Partition test was carried out using three fresh samples of blood (1ml) mixed with 500µl of 
100µg/ml standard solution of 4ASA. The mixture was maintained in constant stirring at 
room temperature for ten minutes and analyzed by HPLC. 
3.5 Bioavailability 
Each rat received an oral dose of minigranules containing 25mg of 4ASA.  Three hours after 
administration of minigranules, the rats were anesthetized with an intra peritoneal 
pentobarbital 10% (ABBOT, Ringis, France) at the dose of 100µl/100g (re-injected with 
10µl/100g as necessary). The internal carotid artery was cannulated via 4cm paratracheal 
incision, and blood samples were taken at 0.5, 1, 2, 3 and 4 hours after anesthesia.  
Rats were killed at the end of experiments by exsanguinations. These samples were collected 
into eppendorf tubes containing 500µl of citrate buffer (0.129M) and kept on ice for at least 
30 min. 
Plasma was obtained by centrifugation (Eppendorf centrifuge, Germany) at 3500 rpm for 10 
min and transferred to clean test tubes. After vortexing for 1 min using a Heidolph Top-mix 
94323 (Bioblock scientific, Germany), plasma samples were analyzed by HPLC method. 
Analyte concentrations were calculated by using an account of the factor of dilution. 
4. Results and discussion 
4.1 Chromatographic conditions 
Experiments were carried out with 10 up to 90% of acetonitrile and water as a mobile phase. 
The best peak shape and the maximum of separation were obtained with a binary mixture: 
water - acetonitrile (70% and 30% respectively). A minimum of retention time (Rt=4.3-4.8) 
with good peak resolution was obtained under a flow of 1ml.min1. 
The optimum wavelength for analyte detection with adequate sensitivity was found to be 
300nm. 
Retention time was very sensitive to the freshness or ageing of mobile phase. 
4.2. Validation of the method 
4.2.1 Specificity/selectivity  
A chromatogram was obtained from blank samples. No peak corresponding to the 
endogenous compounds was detected at the analyte retention time (4.3-4.8min) at 300nm. It 
means that the developed method is selective in relation of the used carrier for pellet 
formulation. 
4.2.2 Linearity  
Seven-point linearity curve was constructed for three consecutive days. Samples were 
quantified using 
concentrations – peak area relationships and were calculated by the simple regression 
analysis. The plots of peak area ratios versus concentrations of all analytes were found to be 
linear within the concentration range (Figure 2). 
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Fig. 2. Linearity of quantitative method by HPLC. Bars represent standard deviations of the 
mean (n = 5) 
4.2.3 Accuracy and precisions 
The results were expressed as percent recoveries of the particular components in the 
samples. The average percent recoveries (±RSD) were respectively in the range of 97.3±0.9 - 
99±1.7 (Table 2). 
 
Concentration (mg/ml) 0,005 0,0075 0,01 
Mean of AUC 329,747 489,049 725,458 
RSD (%) 0,740 1,874 0,51 
Table 2. Accuracy of the proposed method (n =10). AUC:  Area Under  Curve 
The results of intra-day and inter-day precision experiments are indicated according to the 
averages and relative standard deviations (RSD). Inter-day and intra-day precision given by 
relative standard deviation (%R.S.D.) of quality control samples were ≤ 3.3%. The calculated 
values are presented onto (Table 3). 
 
 
Table 3. Intra and inter-day precision of 4ASA quantification with area (UA) andRelative 
Standard Deviation (RSD) (n=3).               
y = 102.4x + 26.789
R² = 0.9984
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4.2.4 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
The results showed a less significant limit of detection (105ng/ml) compared to the limit of 
quantification (305ng/ml). 
4.2.5 Recovery test 
The overall mean recoveries calculated were 80, 100 and 120 for low, medium and high 
quality control samples respectively. A linear curve was obtained meaning proportional 
analyte amount (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Chart of the test of recovering: Bars represent standard deviations of the mean (n=9).  
 
4.2.6 Robustness 
Two–level fractional factorial design were applied in this method. The operational 
parameters do not lead to essential changes of the performance of the chromatographic 
system except the wavelength. Only the wavelength seemed to influence the robustness of 
the method. The interaction between the acetonitrile ratio and the flow rate didn’t seem to 
have any effect on the robustness (Figure 4). 
The obtained values were accurate and RSD values didn’t exceed 3.3%. On the other hand 
the retention time varied quickly from 2.98 to 5.28 min for each modified parameter. 
Acetonitrile change ratio would change the polarity of the mobile phase while pH could 
modify the analyte protonation. 
4.2.7 Study of 4ASA stability 
Three aliquots were used during this experiment which lasted 6 hours. The medium of 
dissolution was maintained with 37°C, in constant stirring with 100 rpm to simulate 
gastrointestinal conditions. The results showed a relative stability of 93.5% (Figure 5).  
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Fig. 4. Histogram representing robustness test of the method. Bars represent standard 
deviations of the mean   (n=5). 
 
 
 
Fig. 5. Study of 4ASA stability during 6h. Bars represent standard deviations of the mean (n=3) 
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The determination of 4ASAconcentration following the degradation, was a positive point on 
the specificity of the drug. 
It would mean that the first breackdowned products did not absorb at 300nm. However new 
peaks at lower retention time (<3min) were detected on seven day-old samples at 
300nm.The later consideration deals with the specificity of the method and its ability to 
separate degradation products for pure drug. 
4.3 Application to biological samples 
The validated analytical method was applied to male Sprague-Dawley rats. 
Compared to the results given by working standard solutions, good peak shape and 
acceptable sensitivity were obtained with the same mobile phase (acetonitrile /water 30:70) 
from diluted plasma samples containing 4ASA. Good precision (CV=3.39%) and 
reproducibility were also observed during 4ASA quantification in plasma samples (Table 4).  
 
 Area % 
Mean 8849,978 100,7479 
RSD 152,8166 2,718627 
Table 4. Evaluation of the Intra assay precision   (n=8) 
The accuracy of these values was confirmed by back calculating the concentration of the 
calibrations standards. 
The retention time was from 4.3 to 5.2 min and did not interfer with other compounds from 
plasma. This period was closed to that obtained with those obtained with aqueous solution 
(4.3-4.8min). The concentration range (10-100µg/ml) in plasma is shorter than the aqueous 
medium concentration (1 to 125µg/ml). The regression equation was Y=88.72 x-88.38 and 
coefficient of correlation (r2) was 0,999.With regard to the partition test, plasma level of 
4ASA reached a maximum of 101.95% (Figure 6).  
 
 
Fig. 6. Plasmatic concentration of 4ASA after partition-ratio. 
Bars represent standard deviations (n=5) 
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The average recovery of assay was 93.54%, 100.89% and 100.23% for low, medium and high 
concentrations of 4ASA in plasma respectively (Table 5).  
 
Concentration (µg/ml) RSD  (%)  
Expected Measured  
25 23,39 1,74 
50 51,45 3,28 
100 100,3 1,65 
Table 5. Responses in recovery tests at low, mean and high value. Mean ±RSD   
Stability tests were investigated using the procedure described above. The results indicated 
that 4ASA was stable in plasma at -4°C for 24h (Figure 7).  
 
 
 
Fig. 7. Stability test of 4ASA in plasma after 48h at room temperature (RT) and at 4°C.            
Bars represent standard deviations of the mean (n=5). 
Since 4ASA was degraded in human plasma in 24 hours at room temperature and would be 
useful for immediate-release solid oral dosage forms. The profile of bioavailability test curve 
was characteristic of a dosage form with extended release. Because the plasma content of 
4ASA was almost constant, it could mean that equilibrium of the balance absorption/ 
degradation was maintained (Figure 8). 
We notice that stability of the analyte during sample collection was investigated using the 
procedure described above. In connection with bioavailability, these results were 
unexpected because the concentration remains relatively constant.  
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Fig. 8. Plasma concentration-time profile after i.v. administration of 25 mg/kg   4- ASA after 
7.5h. Bars represent standard deviations of the mean (n=4). 
5. Conclusion 
In pharmaceutical analysis, often a method validation is required in order to meet the strict 
regulations, set by the regulatory authorities. This method was then developed and 
validated for the determination of 4ASA. Thus specificity, precision, accuracy, linearity, 
recovery and the limits were acceptable with the execution run time for control studies. It 
would be very useful for release profile study in simulated intestinal medium of the analyte 
in question. These results indicated that the RP-HPLC method was specific for the 
determination of 4ASA in plasma, under the chromatographic conditions employed. 
Through this method the retention time was reduced considerably compared to previous 
results obtained by Gennaro et al [13]. With these present results it is possible to save time 
and solvents used to constitute the mobile phase. In addition, studies in plasma indicated 
that this method is suitable for pharmacokinetic studies.  
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